About Saeed Sadiq

Dr Saeed Sadiq Hamid is The Ibne Sina Professor of Medicine and Chairman, Department of Medicine at The Aga Khan University, Karachi, Pakistan. He graduated from King Edward Medical College, Lahore in 1981, and has been affiliated with AKU since 1990. He completed his postgraduate training in Medicine and Gastroenterology in the UK, and in Hepatology at the University of Texas Southwestern Medical School, Dallas, USA.

His research interests include Viral Hepatitis and Acute Liver Failure. He has been the recipient of basic and clinical research grants, including clinical trials. He has a total of 145 peer reviewed publications and three book chapters to his credit, and currently serves as an associate editor for Hepatology International, the official journal of APASL.

Dr Hamid has been a Member of the Executive Council, Asian Pacific Association for the Study of the Liver, 2006-2010, and currently also serves as President, Pakistan Society for the Study of Liver Diseases. He has been a long serving member of the WGO Guidelines and Publications committee and also a member of many guideline development groups of the APASL. He chaired the WHO Guidelines Development Group on HCV treatment guidelines, which were released in April 2016.

This speaker will be presenting at the following session(s)

  • Hepatitis in children


    Day: 2 November

    Time: 18:00

    This evening side meeting looks at hepatitis in children and adolescence. The session will explore some of the recent advances in pediatrics as well as the unique challenges that still need to be overcome within this area.


    • Global overview of hepatitis in children: WHO perspective.
      Prof. Philippa Easterbook, World Health Organization
    • Towards elimination of HBV in Children: prevention perspective.
    • Towards elimination of HCV in children: clinical and treatment perspective.
      Prof. Manal El-Sayed, Ain Shams University, Egypt
    • Panel discussion.
      Prof Saeed Hamid (Pakistan), Prof Funmi Lesi (Nigeria), Prof Gilda Porta (Brazil)
  • Options for countries with access to generic hepatitis medicines

    Ballroom 2

    Day: 2 November

    Time: 12:00

    Chair: Dr. Jean Damascène Makuza, Rwanda Biomedical Center and Tracy Swan, Médecins Sans Frontières


    • Country example: Rwanda.
      Dr. Jean Damascène Makuza, Rwanda Biomedical Center
    • The impact of generics in scaling up treatment.
    • Dr. Saeed Hamid, The Aga Khan University, Pakistan
    • Voluntary licensing.
      Greg Perry, Medicines Patent Pool
    • Basics of access to medicines for hepatitis programme managers.
    • Madisyn Lu, Clinton Health Access Initiative
    • Q & A session.